MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
Molecular Weight:
517.6
Purity:
98.06%
CAS Number:
[875337-44-3]
Formula:
C26H20FN5O2S2
Target:
VEGFR|||Apoptosis|||c-Met/HGFR
T6351
* VAT and and shipping costs not included. Errors and price changes excepted